D. E. Shaw & Co., Inc. Vericel Corp Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Vericel Corp stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 23,017 shares of VCEL stock, worth $1.32 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,017

Holding current value

$1.32 Million

% of portfolio

0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$42.25 - $53.56 $716,306 - $908,056	-16,954 Reduced 42.42%	23,017 $972,000
Q2 2024 Aug 14, 2024	BUY	$41.71 - $52.9 $433,700 - $550,054	10,398 Added 35.16%	39,971 $1.83 Million
Q1 2024 May 15, 2024	SELL	$32.52 - $52.33 $2.37 Million - $3.81 Million	-72,866 Reduced 71.13%	29,573 $1.54 Million
Q4 2023 Feb 14, 2024	SELL	$30.85 - $37.09 $2.37 Million - $2.85 Million	-76,750 Reduced 42.83%	102,439 $3.65 Million
Q3 2023 Nov 14, 2023	BUY	$31.69 - $39.25 $3.16 Million - $3.92 Million	99,770 Added 125.62%	179,189 $6.01 Million
Q2 2023 Aug 14, 2023	BUY	$29.0 - $38.37 $186,963 - $247,371	6,447 Added 8.83%	79,419 $2.98 Million
Q1 2023 May 15, 2023	BUY	$23.85 - $31.34 $145,294 - $190,923	6,092 Added 9.11%	72,972 $2.14 Million
Q4 2022 Feb 14, 2023	SELL	$17.65 - $27.37 $749,771 - $1.16 Million	-42,480 Reduced 38.84%	66,880 $1.76 Million
Q3 2022 Nov 14, 2022	BUY	$22.62 - $32.54 $595,177 - $856,192	26,312 Added 31.68%	109,360 $2.54 Million
Q2 2022 Aug 15, 2022	BUY	$22.88 - $39.45 $1.61 Million - $2.78 Million	70,393 Added 556.25%	83,048 $2.09 Million
Q1 2022 May 16, 2022	BUY	$31.69 - $43.29 $401,036 - $547,834	12,655 New	12,655 $484,000
Q1 2020 May 15, 2020	SELL	$7.25 - $19.22 $717,300 - $1.9 Million	-98,938 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$13.77 - $19.2 $1.13 Million - $1.58 Million	-82,146 Reduced 45.36%	98,938 $1.72 Million
Q3 2019 Nov 14, 2019	SELL	$14.93 - $19.83 $1.01 Million - $1.35 Million	-67,859 Reduced 27.26%	181,084 $2.74 Million
Q2 2019 Aug 14, 2019	SELL	$15.01 - $18.89 $281,242 - $353,941	-18,737 Reduced 7.0%	248,943 $4.7 Million
Q1 2019 May 15, 2019	BUY	$16.23 - $20.29 $2.58 Million - $3.23 Million	159,041 Added 146.39%	267,680 $4.69 Million
Q4 2018 Feb 14, 2019	SELL	$10.77 - $18.44 $492,092 - $842,542	-45,691 Reduced 29.61%	108,639 $1.89 Million
Q3 2018 Nov 14, 2018	BUY	$9.1 - $14.8 $734,661 - $1.19 Million	80,732 Added 109.69%	154,330 $2.18 Million
Q2 2018 Aug 14, 2018	BUY	$9.6 - $14.6 $706,540 - $1.07 Million	73,598 New	73,598 $714,000

Others Institutions Holding VCEL

# of Institutions

276

Shares Held

48.8M

Call Options Held

91.8K

Put Options Held

23.2K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.7B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account